93215 ⎘
Derivatives of urea, i.e. compounds containing any of the groups , the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
Sub-classes:Alkylphenyl Substituted Compounds, Compositions and Methods of Use
#2NOVEL MONOMER AND CHEMICALLY RECYCLABLE POLYMER MATERIAL COMPRISING THE SAME
#31,4-DIUREAS AND 1,4-DITHIOUREAS AND USES THEREOF
#4MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#5COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#6MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#7MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#8COMPOSITIONS AND METHODS OF MAKING EXPANDED HEMATOPOIETIC STEM CELLS USING DERIVATIVES OF FLUORENE
#9Substituted Ureas and Methods of Making and Using Same
#10NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME
#11Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto
#12Compositions and methods for the treatment of cancer
#13Device for detecting hydrosulfide
#14[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
#15VASCULAR ADHESION PROTEIN-1 (VAP-1) MODULATORS AND THERAPEUTIC USES THEREOF
#16NOVEL UREA COMPOUNDS AND BIOISOSTERES THEREOF AND THEIR USE FOR TREATING INFLAMMATION AND INFLAMMATION-RELATED PATHOLOGIES
#17Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH)
#18Amide compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases and therapeutic agent for cancer that use the same
#19MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#20Substituted ureas and methods of making and using same
#21Therapeutic compounds as inhibitors of the orexin-1 receptor
#22SOLID DRUG FORM OF N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTYL)METHYL)UREA HYDROCHLORIDE AND COMPOSITIONS, METHODS AND KITS RELATED THERETO
#23Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene
#24Adamantylmethylamine derivative and use thereof as pharmaceutical
#25Urea derivatives and methods of use thereof
#26Substituted ureas and methods of making and using same
#27Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#28Inhibitors for soluble epoxide hydrolase (SEH) and fatty acid amide hydrolase (FAAH)
#29Oil gelator
#30Synthesis of carbamate or urea compounds
#31Selective histone deactylase 6 inhibitors
#32Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#33Ethynylbenzene derivatives
#34Herbicidal compounds
#35Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto
#36SUBSTITUTED TETRACYCLINE COMPOUNDS
#37Therapeutic compounds as inhibitors of the orexin-1 receptor
#38Compounds Which Have a Protective Activity with Respect to the Action of Toxins and of Viruses with an Intracellular Mode of Action
#39OMEGA-3 ANALOGUES
#40Selective histone deactylase 6 inhibitors
#41FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
#42FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
#43High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixture-based libraries
#44TrkA kinase inhibitors, compositions and methods thereof
#45Selective histone deactylase 6 inhibitors
#46Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto
#47Colour protection detergent
#48S1P receptors modulators and their use thereof
#49Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors
#50OMEGA-3 ANALOGUES
#51Alpha hydroxy amides
#52Compounds and methods for treating mammalian gastrointestinal microbial infections
#53Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
#54Compounds and methods for treating mammalian gastrointestinal microbial infections
#55Selective histone deactylase 6 inhibitors
#56COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR
#57Substituted tetracycline compounds
#58Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators
#59Isocyanate-containing prepolymer and method for making the same
#60Isocyanate-containing prepolymer and method for making the same
#61Synthesis of galanal compounds and analogues thereof
#62Substituted hydroxamic acids and uses thereof
#63Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8
#64Glutamine derivatives as deodorants
#65Inhibitors of the shiga toxins trafficking through the retrograde pathway
#66S1P receptors modulators and their use thereof
#67Synthetic ion channels
#68Ethynylbenzene derivatives
#69Bisurea gelling agents and compositions
#70MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#71Urea compounds and use thereof for inhibiting apoptosis
#72NOVEL AMPHIPHILES
#73COMPOUNDS AND THERAPEUTIC USES THEREOF
#74(bis)urea and (bis)thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
#75Electrophotographic photosensitive member, process cartridge, electrophotographic apparatus, method of producing electrophotographic photosensitive member, and urea compound
#76Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#772-adamantylurea derivatives as selective 11β-HSD1 inhibitors
#78Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#79Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
#80Compounds and methods for treating mammalian gastrointestinal microbial infections
#81METHOD FOR MAKING CARBAMATES, UREAS AND ISOCYANATES
#82DIACYLETHYLENEDIAMINE COMPOUND
#83Preparation of monobasic phosphate ionophores
#84Phosphine ligands for catalytic reactions
#85SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
#86Partially fluorinated ureas and amides
#87Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators
#88S1P receptors modulators and their use thereof
#89SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
#90Inhibitors of the Shiga toxins trafficking through the retrograde pathway
#91Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8
#922-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS
#93SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY
#94Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#95SUBSTITUTED PHENOXYBENZAMIDES
#96SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#97Phenylurea inhibitors of the SOAT-1 enzyme and pharmaceutical/cosmetic compositions comprised thereof
#98Production of N-aryl carbamates and N-aryl isocyanates
#99Phenylurea inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereof
#100Aminotetralin-derived urea modulators of vanilloid VR1 receptor
#101Method for making carbamates, ureas and isocyanates
#102Rho kinase inhibitors
#103N- (2-aminophenyl) benzamide derivative having urea structure
#104Process for the preparation of urethanes
#105Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#106Indane amides
#1072-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
#108Compositions and methods for modulating a kinase cascade
#109TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#110Glucagon Antagonists/Inverse Agonists
#111SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#112Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
#113Antithrombotic diamides
#114METHOD FOR PROVIDING NANOWEB COMPOSITE MATERIAL
#115Partially fluorinated ureas and amides
#116Methods and compositions for derepression of IAP-inhibited caspase
#1171,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors
#118Biaromatic compounds that modulate PPAR-receptors
#119Substituted Ureas and Carbamates
#120Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents
#121Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
#122Aminotetralin-derived urea modulators of vanilloid VR1 receptor
#123Organic Compunds
#124Histone deacetylase inhibitors
#125Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors
#126Novel Biphenyl Compounds And Their Use
#127Methods for carbon istope labeling synthesis by rhodium-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
#128Urea derivatives as integrin a4 antagonists
#129Amide or thioamide derivatives and their use in the treatment of pain
#130INHIBITORS OF FATTY ACID AMIDE HYDROLASE
#131Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents
#132Functional monomers for molecular recognition and catalysis
#133Peptidomimetic ligands for cellular receptors and ion channels
#134Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain
#135UII-modulating compounds and their use
#136NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF
#137(Meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained
#138Cell adhesion inhibitors
#139Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
#140Tricyclic steroid hormone nuclear receptor modulators
#141Use of urea variants as affinity ligands
#142Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
#143Novel anticancer compounds
#144Glucagon antagonists/inverse agonists
#145Aminotetralin-derived urea modulators of vanilloid VR1 receptor
#1462,3-Oxidosqualene-lanosterol cyclase inhibitors
#147Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
#148Functional monomers for molecular recognition and catalysis
#149Urea derivatives
#150Substituted tetracycline compounds
#151Carboxamide derivatives
#152Prodrugs of 9-aminomethyl tetracycline compounds
#153GlyT2 modulators
#154Benzylether amine compounds useful as CCR-5 antagonists
#155Peptidomimetic ligands for cellular receptors and ion channels
#156Glucagon antagonists/inverse agonists
#157Novel compounds useful in pain management
#158Urea linker derivatives for use as PPAR modulators
#159High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixture-based libraries